Quoin Pharmaceuticals, Ltd. ( QNRX) - Key Metrics
QNRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | $0 | -$1.77 | -$1.72 | -$1.72 |
| 2025Q4 | $0 | -$2.90 | -$3.39 | -$3.39 |
| 2025Q3 | $0 | -$6.71 | -$3.78 | -$3.78 |
| 2025Q2 | $0 | -$6.28 | -$6.27 | -$6.27 |
QNRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | 0% | -0.93 |
| 2025Q4 | 0% | -1.24 |
| 2025Q3 | 0% | -0.27 |
| 2025Q2 | 0% | -0.37 |
QNRX
Price: $3.99
52 week price:
Earnings Per Share: -5.50 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 102500
Market Capitalization: 9.1 million